Repligen (RGEN) Tops Q2 EPS by 27c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Repligen (RGEN) Tops Q2 EPS by 27c

Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

July 27, 2021 7:30 AM EDT

Reported revenue was $163.0 million for the quarter, representing year-over-year growth of 86% and organic growth of 69%Revenue guidance raised to $625-$645 million for full year 2021Acquisition of hollow fiber innovator Polymem S.A. completed July 1, 2021

WALTHAM, Mass., July 27, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its second quarter of 2021. Provided in this press release are financial highlights for the three- and six- month periods ended June 30, 2021,... More